NEW ORLEANS — Results presented here showed simultaneous amputation with osseointegration yielded similar improvements in mobility and outcomes as well as no differences in adverse event rate as osseointegration for an existing amputation.
“These results could mean that a lot more patients who end up having amputations, especially elective amputations, may be getting amputations with osseointegration in the same setting, especially when we are not faced with an active infection at the time of the amputation,” Taylor J. Reif, MD, an orthopedic surgeon at the Osseointegration

Luminopia has a clinically meaningful benefit for children with severe amblyopia, according to a study presented at the American Association for Pediatric Ophthalmology and Strabismus meeting.
Other studies found that the headset-based therapy had particular benefit for older children and that amblyopia recurred less frequently after Luminopia treatment.
“We’re seeing growing evidence to support Luminopia use in a diverse group of patients across a broad spectrum of amblyopia,” Shelley Hancock, senior director of medical affairs at Luminopia, told Healio.
The studies were

CHICAGO — A study of nursing home residents demonstrated that vaccination against respiratory syncytial virus reduced their risk for illness, although protection waned over time for some.
Researchers measured the protective impact of Abrysvo, Pfizer’s RSV vaccine, among 15,078 residents living in Veterans Health Administration nursing homes over the course of two seasons.
They presented their findings at SHEA Spring, the Society for Healthcare Epidemiology of America’s annual conference.
According to the researchers, it was the first study to assess RSV vaccine effectiveness among nursing home

Editor’s note: This is a developing news story. Please check back soon for updates.
Oculus received FDA clearance for its Pentacam Cornea OCT system, according to a company press release.
Pentacam Cornea OCT features a combination of Scheimpflug technology and high-resolution, pericentric optical coherence tomography imaging. Both measurements can be taken at the same time at the same location, according to the release.
The system is compatible with existing Oculus Pentacam examination data, which the company said will simplify follow-up exams and progression analysis.
“We are excited to

Individuals who have never been married develop cancer at significantly higher rates than those who married, according to new study findings.
An evaluation of more than 60 million adults showed those who had never been married had double the incidence rates of multiple malignancies, and those disparities could be seen across gender, race and ethnicity, and age.
Furthermore, the cancers with the greatest gaps based on marital status have significant associations with modifiable risk factors, including HPV status and tobacco and alcohol use.
“Marriage is a risk-stratifier that has been ignored so

According to a study published in JAMA Network Open, 8.3% of U.S. adults — equivalent to about 21.3 million people — reported ever having long COVID in 2024.
Long COVID can be tricky to diagnosis, and its treatment brings forth a host of other questions, particularly considering research’s limited findings so far.
There has been some progress. A study recently published in Annals of Internal Medicine found fluvoxamine to be potentially effective for improving quality of life and reducing fatigue in patients with long COVID.
“Although fatigue is a common symptom, it is not

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.
This month we will focus on a revolutionary milestone in the treatment of endothelial dysfunction. Building upon the pioneering work of Shigeru Kinoshita, MD, PhD, and thanks to the innovative spirit and commitment of Aurion Biotech, corneal endothelial cell therapy has now reached the market in Japan, and phase 3 trials are soon to begin in the U.S. Minimally invasive and highly effective, easier

A 44-year-old woman presented to an outside ophthalmology clinic with significant nausea, blurry vision in the right eye and right-sided headache.
She was found to have elevated IOP that did not respond to maximum medical therapy including topical IOP-lowering medications and oral acetazolamide. She was referred to the Tufts New England Eye Center glaucoma clinic due to concern for acute angle closure. She had no significant medical or surgical history. She had no known allergies, and there was no known alcohol or drug abuse history. Family history was noncontributory.
On initial exam, the

The conjunctiva is the outermost ocular epithelial layer, lining the ocular surface.
Trauma, insect bite allergy or autoimmune conditions can cause conjunctival necrosis. Rarely, post-surgical intervention after excess cautery or mitomycin C usage can lead to conjunctival necrosis. In this report, we see a young patient with post-phacoemulsification conjunctival necrosis and ulceration.
A 33-year-old woman who had blurred vision was diagnosed with bilateral presenile cataract and underwent uneventful phacoemulsification in her left eye under local anesthesia. Her initial 1-week postoperative

LOS ANGELES — A compassionate neurofeedback game that can identify fatigue aims to help patients with MS, according to a poster presented at Cedars-Sinai’s eighth annual iteration of its Virtual Medicine Conference, vMed.
Before developing AlphaRise, a 2D brain-computer interface game, Ned Shoaei, an MFA student in game development in interactive design at Savannah College of Art and Design, assessed responses from 146 patients with MS who took a 21-question survey she conducted with the National MS Society.
The mean Modified Fatigue Impact Scale (MFIS) fatigue score in this population was